The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cyclic antidepressants and the risk of sudden cardiac death
Abstract
Background: Tricyclic and other related cyclic antidepressants (TCAs), used frequently for the treatment of depression and several other indications, have cardiovascular effects that may increase the risk of sudden cardiac death. We thus sought to quantify the risk of sudden cardiac death among TCA users, according to dose, as well as among users of selective serotonin reuptake inhibitors (SSRIs). Methods: We conducted a retrospective cohort study in Tennessee Medicaid, from Jan 1, 1988, through Dec 31, 1993, which included large numbers of antidepressant users and computer files describing medication use and comorbidity. The cohort included 1,282,091 person‐years of follow‐up for persons aged 15 to 84 years who were not in a nursing home and were free of life‐threatening noncardiac illness. This included 58,956 person‐years for current use of TCAs alone, 6291 person‐years for SSRIs only, and 96,220 person‐years for former use. Results: The cohort included 1487 confirmed sudden cardiac deaths occurring in the community. When compared with nonusers of antidepressants, current users of TCAs had a dose‐related increase in the risk of sudden cardiac death. Rate ratios increased from 0.97 (95% confidence interval [CI], 0.72–1.29) for doses lower than 100 mg (amitriptyline or its equivalent) to 2.53 (95% CI, 1.04–6.12) for doses of 300 mg or more (P = .03, test for dose‐response). The rate ratio for SSRIs was 0.95 (95% CI, 0.42–2.15). There was no evidence that TCA doses lower than 100 mg increased the risk of sudden cardiac death in subgroups defined by pre‐existing cardiovascular disease, female sex, age 65 years or older, or use of amitriptyline. Conclusions: Our data suggest that SSRI antidepressants and TCAs in doses of less than 100 mg (amitriptyline equivalents) did not increase the risk of sudden cardiac death. However, higher doses of TCAs were associated with increased relative risk, which suggests that such doses should be used cautiously, particularly in patients with an elevated baseline risk of sudden death. Clinical Pharmacology & Therapeutics (2004) 75, 234–241; doi: 10.1016/j.clpt.2003.09.019
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression Following Myocardial Infarction: Impact on 6-Month Survival
Frasure-Smith, N. (1993) · JAMA · doi:10.1001/jama.1993.03510150053029 · Cited by 1,939
Fish Consumption and Risk of Sudden Cardiac Death
Albert, C. M. (1998) · JAMA · doi:10.1001/jama.279.1.23 · Cited by 990
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
Drugs and the treatment of psychiatric disorders
Baldessarini, R. J. (1996) · Medical Entomology and Zoology · Cited by 683
Clinical classification of cardiac deaths.
Hinkle, L. E., & Thaler, H. T. (1982) · Circulation · doi:10.1161/01.cir.65.3.457 · Cited by 638
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
Reilly, J., Ayis, S., Ferrier, I., Jones, S., & Thomas, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02035-3 · Cited by 602
Sudden Cardiac Death: Epidemiology, Transient Risk, and Intervention Assessment
Myerburg, R. J., Kessler, K. M., & Castellanos, A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00006 · Cited by 528
Comparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart Disease
Roose, S. P. (1998) · JAMA · doi:10.1001/jama.279.4.287 · Cited by 453
Diuretic Therapy for Hypertension and the Risk of Primary Cardiac Arrest
Siscovick, D. S., Raghunathan, T. E., Psaty, B. M., Koepsell, T. D., Wicklund, K. G., Lin, X., Cobb, L., Rautaharju, P. M., Copass, M. K., & Wagner, E. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302603 · Cited by 434
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 429
Self-citationRecall Accuracy for Prescription Medications: Self-report Compared with Database Information
West, S. L., Savitz, D. A., Koch, G., Strom, B. L., Guess, H. A., & Hartzema, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117563 · Cited by 352
USE OF MEDICAID DATA FOR PHARMACOEPIDEMIOLOGY
RAY, W. A., & GRIFFIN, M. R. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115198 · Cited by 315
Self-citationThe safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered
Glassman, A. H. (1993) · JAMA · doi:10.1001/jama.269.20.2673 · Cited by 245
Magnesium therapy for torsades de pointes
Tzivoni, D., Keren, A., Cohen, A. M., Loebel, H., Zahavi, I., Chenzbraun, A., & Stern, S. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90025-0 · Cited by 226
Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death
Witchel, H. J., Hancox, J. C., & Nutt, D. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00010 · Cited by 221
Amitriptyline: A Review of its Pharmacological Properties and Therapeutic Use in Chronic Pain States
Bryson, H. M., & Wilde, M. I. (1996) · Drugs & Aging · doi:10.2165/00002512-199608060-00008 · Cited by 204
Clinical Geriatric Psychopharmacology
(1985) · Journal of Gerontology · doi:10.1093/geronj/40.6.768 · Cited by 160
Tricyclic Antidepressants in Depressed Patients With Cardiac Conduction Disease
Roose, S. P. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150093011 · Cited by 157
British psychiatric morbidity survey
Jenkins, R., Bebbington, P., Brugha, T. S., Farrell, M., Lewis, G., & Meltzer, H. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.1.4 · Cited by 152
Comparing Sources of Drug Data about the Elderly
Johnson, R. E., & Vollmer, W. M. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb02872.x · Cited by 148
CARDIOTOXICITY OF AMITRIPTYLINE
Moir, D. C., Cornwell, W. B., Dingwall-Fordyce, I., Crooks, J., O'MALLEY, K., Turnbull, M. J., & Weir, R. D. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91958-7 · Cited by 145
USE OF AUTOMATED DATABASES FOR PHARMACOEPIDEMIOLOGY RESEARCH
Strom, B. L., & Carson, J. L. (1990) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036064 · Cited by 138
Teschemacher, A. G., Seward, E. P., Hancox, J. C., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702800 · Cited by 135
Hannonen, P. (1998) · Rheumatology · doi:10.1093/rheumatology/37.12.1279 · Cited by 133
Marcus, G. M., Cobb, L. A., Edwards, J. E., Kuller, L. H., Moss, A. J., Bigger, J. T., Fleiss, J. L., Rolnitzky, L. M., & Serokman, R. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91295-7 · Cited by 132
The use of antidepressant drugs in patients with heart disease.
Glassman, A. H., Rodríguez, A. I. E., & Shapiro, P. A. (1998) · PubMed · Cited by 125
Review of the cardiovascular effects of heterocyclic antidepressants.
Glassman, A. H., & Preudʼhomme, X. (1993) · PubMed · Cited by 99
Symptom relief with amitriptyline in the Irritable Bowel syndrome
Rajagopalan, M., Kurian, G. P., & John, J. K. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00723.x · Cited by 98
Block of Human Heart hH1 Sodium Channels by Amitriptyline
Nau, C., Seaver, M., Wang, S.-Y., & Wang, G. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35384-4 · Cited by 95
Clinical Geriatric Psychopharmacology
Targum, S. D. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.2.248 · Cited by 94
Roose, S. P., Glassman, A. H., Giardina, E. V., Johnson, L. L., Walsh, B. T., & Bigger, J. T. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198708000-00007 · Cited by 85
Blockade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline
Jo, S., Youm, J. B., Lee, C. O., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703222 · Cited by 78
DEPRESSION AND ANXIETY DISORDERS
Brown, C. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70199-6 · Cited by 74
METHODOLOGICAL ISSUES IN EVALUATING EXPANDED MEDICAID COVERAGE FOR PREGNANT WOMEN
Piper, J. M., Ray, W. A., Griffin, M. R., Fought, R. L., DAUGHTERY, J. R., & Mitchel, E. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115692 · Cited by 72
Self-citationHerrmann, H. C., Kaplan, L. M., & Bierer, B. E. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80155-6 · Cited by 66
Iglehart, J. K. (2003) · New England Journal of Medicine · doi:10.1056/nejmhpr035376 · Cited by 58
A Comparison of Patient Drug Regimens as Viewed by the Physician, Pharmacist and Patient
Leister, K. A., Edwards, W. A. (., Christensen, D. B., & Clark, H. (1981) · Medical Care · doi:10.1097/00005650-198106000-00008 · Cited by 44
Cardiovascular effects of paroxetine
Kuhs, H., & Rudolf, G. A. E. (1990) · Psychopharmacology · doi:10.1007/bf02244107 · Cited by 37
Coupland, N., Wilson, S., & Nutt, D. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100118 · Cited by 36
(1980) · International Journal of Epidemiology · doi:10.1093/ije/9.3.280 · Cited by 27
Meeting the challenge of tobacco use within the Medicaid population.
Carr, R. M., Christiansen, B. A., Jehn, L., & Matitz, D. (2001) · PubMed · Cited by 13
Cited by
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Metadata
- Authors
- Ray, W. A., Meredith, S., Thapa, P. B., Hall, K., & Murray, K. T.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2004-03
- Volume
- 75
- Issue
- 3
- Pages
- 234-241
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2113377040
- Cited by
- 274
- References
- 41
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.